Cargando…
The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study
BACKGROUND: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool is intended to be used in the design phase of trials to help investigative teams design trials in-line with their purpose. Our team applied this tool to an ongoing trial (BLISTER) to determine whether the initial suggest...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423061/ https://www.ncbi.nlm.nih.gov/pubmed/22540678 http://dx.doi.org/10.1186/1745-6215-13-50 |
_version_ | 1782241081711132672 |
---|---|
author | Bratton, Daniel J Nunn, Andrew J Wojnarowska, Fenella Kirtschig, Gudula Sandell, Anna Williams, Hywel C |
author_facet | Bratton, Daniel J Nunn, Andrew J Wojnarowska, Fenella Kirtschig, Gudula Sandell, Anna Williams, Hywel C |
author_sort | Bratton, Daniel J |
collection | PubMed |
description | BACKGROUND: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool is intended to be used in the design phase of trials to help investigative teams design trials in-line with their purpose. Our team applied this tool to an ongoing trial (BLISTER) to determine whether the initial suggestion among some team members that the trial could be described as largely pragmatic was the consensus. METHODS: Each of the six members of the BLISTER trial team was sent a blank PRECIS wheel to independently complete. The results obtained were averaged and plotted on a single PRECIS wheel to illustrate the degree of pragmatism of the trial. RESULTS: The trial team found that the design of the trial was closest to the pragmatic end of the pragmatic-explanatory continuum. The strongest consensus was found on the ‘flexibility of the comparison intervention’ and ‘practitioner adherence’ domains (SD = 13). The trial team appeared to disagree most on the ‘eligibility criteria’ (SD = 35) and ‘participant compliance’ (SD = 31) domains, although the large standard deviations were a result of a single outlier in the two domains. CONCLUSION: The PRECIS tool can be used to retrospectively determine the pragmatism of a trial provided enough expertise and information on the trial is available. Illustrating the design of a trial on the PRECIS wheel can help research users more easily identify studies of interest. We hope our recommendations for applying this useful tool will encourage others to consider using it when designing, conducting and reporting studies. TRIAL REGISTRATION: Current Controlled Trials http://www.controlled-trials.com/ISRCTN13704604 |
format | Online Article Text |
id | pubmed-3423061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34230612012-08-21 The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study Bratton, Daniel J Nunn, Andrew J Wojnarowska, Fenella Kirtschig, Gudula Sandell, Anna Williams, Hywel C Trials Methodology BACKGROUND: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool is intended to be used in the design phase of trials to help investigative teams design trials in-line with their purpose. Our team applied this tool to an ongoing trial (BLISTER) to determine whether the initial suggestion among some team members that the trial could be described as largely pragmatic was the consensus. METHODS: Each of the six members of the BLISTER trial team was sent a blank PRECIS wheel to independently complete. The results obtained were averaged and plotted on a single PRECIS wheel to illustrate the degree of pragmatism of the trial. RESULTS: The trial team found that the design of the trial was closest to the pragmatic end of the pragmatic-explanatory continuum. The strongest consensus was found on the ‘flexibility of the comparison intervention’ and ‘practitioner adherence’ domains (SD = 13). The trial team appeared to disagree most on the ‘eligibility criteria’ (SD = 35) and ‘participant compliance’ (SD = 31) domains, although the large standard deviations were a result of a single outlier in the two domains. CONCLUSION: The PRECIS tool can be used to retrospectively determine the pragmatism of a trial provided enough expertise and information on the trial is available. Illustrating the design of a trial on the PRECIS wheel can help research users more easily identify studies of interest. We hope our recommendations for applying this useful tool will encourage others to consider using it when designing, conducting and reporting studies. TRIAL REGISTRATION: Current Controlled Trials http://www.controlled-trials.com/ISRCTN13704604 BioMed Central 2012-04-27 /pmc/articles/PMC3423061/ /pubmed/22540678 http://dx.doi.org/10.1186/1745-6215-13-50 Text en Copyright ©2012 Bratton et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Bratton, Daniel J Nunn, Andrew J Wojnarowska, Fenella Kirtschig, Gudula Sandell, Anna Williams, Hywel C The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title | The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title_full | The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title_fullStr | The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title_full_unstemmed | The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title_short | The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
title_sort | value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423061/ https://www.ncbi.nlm.nih.gov/pubmed/22540678 http://dx.doi.org/10.1186/1745-6215-13-50 |
work_keys_str_mv | AT brattondanielj thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT nunnandrewj thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT wojnarowskafenella thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT kirtschiggudula thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT sandellanna thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT williamshywelc thevalueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT brattondanielj valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT nunnandrewj valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT wojnarowskafenella valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT kirtschiggudula valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT sandellanna valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy AT williamshywelc valueofthepragmaticexplanatorycontinuumindicatorsummarywheelinanongoingstudythebullouspemphigoidsteroidsandtetracyclinesstudy |